Search

everythinglearnresearchcommunity

for

Search:↓

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Hair can be used to measure cancer-related chemicals noninvasively.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Cetuximab can cause unusual hair growth and hair loss.

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Micrografts and minigrafts are safe and effective for hair transplantation in facial and scalp reconstruction, providing high patient satisfaction.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

Overactive signaling in hair follicles can lead to skin cancer.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Vitamin D3 and its receptor are important for hair growth, and understanding receptors could help treat hair graying and skin cancer.